Fig. 3
From: Construction of 11 metabolic-related lncRNAs to predict the prognosis in lung adenocarcinoma
The risk scoring model construction. (A, F) Kaplan-Meier analysis on lung adenocarcinoma patients in the test and validation sets showed that the prognosis of the low-risk group was better. (B, G) The survival rate and survival status of patients with lung adenocarcinoma. (C, H) The distribution of 11 lncRNA risk scores for lung adenocarcinoma patients. (D, I) Heat maps of 11 lncRNAs in the high-risk and low-risk groups. (E, J) ROC curve analysis of lung adenocarcinoma patients